<DOC>
	<DOCNO>NCT00928226</DOCNO>
	<brief_summary>We hope determine maximum tolerate dose 3 session ( i.e. , treatment ) stereotactic radiosurgery treat brain metastasis great 4.2 cm3 size . By increase radiation dose , determine good outcome without great toxicity ( side effect ) patient .</brief_summary>
	<brief_title>Phase I/II Study Fractionated Stereotactic Radiosurgery Treat Large Brain Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>All patient age 18 year old pathologically proven solid tumor malignancy 1 4 brain metastasis , one 4.2 33.5 cm^3 . Systemic therapy : Prior cytoxic systemic therapy must complete &gt; = 5 day prior radiosurgery . No concurrent cytoxic systemic therapy along SRS . Cytoxic systemic therapy start &gt; = 5 day completion SRS . Prior surgery SRS allow long target metastatic lesion study previously treat SRS . Patient must exhibit ability understand willingness sign write informed consent . Life expectancy least 12 week . Patients previously treat whole brain irradiation . Patients whose metastatic lesion question previously treat SRS . The patient great 4 total brain metastasis time initial evaluation . Pediatric patient ( age &lt; 18 ) , pregnant woman , patient unable give inform consent exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>